KRO-01872
collagen
9064-67-9
98% min.
scale-up (10-1,000 kg)
C4H6N2O3R2.(C7H9N2O2R)n
98% min.
scale-up (10-1,000 kg)
C4H6N2O3R2.(C7H9N2O2R)n
KRO-02464
Chondroitin sulfate sodium salt
9082-07-9
98% min.
scale-up (10-1,000 kg)
C42H57N3Na6O43S3
98% min.
scale-up (10-1,000 kg)
C42H57N3Na6O43S3
KRO-00998
Hyaluronic Acid Sodium Salt; HYALURONIC ACID SODIUM SALT
9004-61-9
98% min.
scale-up (10-1,000 kg)
C28H44N2O23
98% min.
scale-up (10-1,000 kg)
C28H44N2O23
KRO-01775
Aloe resin B; Aloesin; Aloersin B
30861-27-9
98% min.
scale-up (10-1,000 kg)
C19H22O9
98% min.
scale-up (10-1,000 kg)
C19H22O9
KRO-13940
palmitoyl pentapeptide; Pal-Lys-Thr-Thr-Lys-Ser-OH; Palmitoyl Pentapeptide; Matrixyl(PAL-KTTKS); Palmitoyl Pentapeptide PAL-Lys-Thr-Thr-Lys-Ser; N2-(1-Oxohexadecyl)-L-lysyl-L-threonyl-L-threonyl-L-lysyl-L-serine; palmitoyl-KTTKS; palmitoyl-Lys-Thr-Thr-Lys-Ser; palmitoyl pentapeptide-3
214047-00-4
98% min.
scale-up (10-1,000 kg)
C39H75N7O10
98% min.
scale-up (10-1,000 kg)
C39H75N7O10
KRO-00752
UNII-A3LEI4P1NB; Prezatide copper acetate; (2S)-6-amino-2-[[(2S)-2-[(2-aminoacetyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoic acid; Prezatide copper acetate [USAN:INN]
130120-57-9
98% min.
scale-up (10-1,000 kg)
C16H28CuN6O6
98% min.
scale-up (10-1,000 kg)
C16H28CuN6O6
KRO-11702
palmitoyl tetrapetide-7
98% min.
scale-up (10-1,000 kg)
KRO-28231
[4-(1H-1,2,4-Triazol-1-yl)phenyl]methanol; (4-[1,2,4]Triazol-1-yl-phenyl)methanol; (4-(1H-1,2,4-Triazol-1-yl)phenyl)methanol; [4-(1,2,4-triazol-1-yl)phenyl]methanol
143426-50-0
98% min.
scale-up (10-1,000 kg)
C9H9N3O
98% min.
scale-up (10-1,000 kg)
C9H9N3O
KRO-27979
1-amino-3-(2-methoxyphenyl)thiourea
40207-02-1
98% min.
scale-up (10-1,000 kg)
C8H11N3OS
98% min.
scale-up (10-1,000 kg)
C8H11N3OS
KRO-00368
androstenone hydrazone
63015-10-1
98% min.
scale-up (10-1,000 kg)
C19H30N2O
98% min.
scale-up (10-1,000 kg)
C19H30N2O
KRO-15338
InChI=1/C3H3BrO2/c4-2-1-3(5)6/h1-2H,(H,5,6)/b2-1; 3t-bromo-acrylic acid; (E)-3-bromoprop-2-enoic acid; (2Z)-3-bromoacrylic acid; 3-bromo-2E-propenoic acid; 2-propenoic acid,3-bromo-,(2Z); (E)-3-Bromopropenoic acid; trans-3-Bromoacrylic acid; 3E-bromoacrylate; (E)-3-bromoacrylic acid
6213-89-4
98% min.
scale-up (10-1,000 kg)
C3H3BrO2
98% min.
scale-up (10-1,000 kg)
C3H3BrO2
KRO-05316
(3S,5S)-3,5-Bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-1-hydroxy-cyclohexanecarboxylic Acid Methyl Ester; 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone monoethanesulphonate; 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone monoethanesulfonate; methyl (3Z)-3-[({4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]phenyl}amino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate ethanesulfonate salt; 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone monoethanesulfonate salt; 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-ethylene]-6-methoxycarbonyl-2-indolinone monoethanesulfonate; methyl (3S,5R)-3,5-di[(tert-butyldimethylsilyl)oxy]-1-hydroxy-cyclohexanecarboxylate; nintedanib ethanesulfonate salt; Ethanesulfonic acid - methyl (3Z)-3-{[(4-{methyl[(4-methyl-1-pipe razinyl)acetyl]amino}phenyl)amino](phenyl)methylene}-2-oxo-6-indo linecarboxylate (1:1); methyl (3S,5S)-3,5-bis[tert-butyl(dimethyl)silyloxy]-1-hydroxy-cyclohexanecarboxylate
656247-18-6
98% min.
scale-up (10-1,000 kg)
C33H39N5O7S
98% min.
scale-up (10-1,000 kg)
C33H39N5O7S
KRO-32540
3-[1-methoxy-1-phenylmeth-(E)-ylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylic acid methyl ester
1168150-46-6
98% min.
scale-up (10-1,000 kg)
C18H15NO4
98% min.
scale-up (10-1,000 kg)
C18H15NO4
KRO-05317
[14C]-Intedanib; Nintedanib; Intedanib; Imidafenacin; Uritos; Staybla
656247-17-5
98% min.
scale-up (10-1,000 kg)
C31H33N5O4
98% min.
scale-up (10-1,000 kg)
C31H33N5O4
KRO-13591
N-[(4-methyl-piperazin-1-yl)-methylcarbonyl]-N-methyl-4-nitroaniline; N-(4-nitrophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide; N-methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)-acetamide; QC-1091
1139453-98-7
98% min.
scale-up (10-1,000 kg)
C14H20N4O3
98% min.
scale-up (10-1,000 kg)
C14H20N4O3
KRO-36468
N-methyl-4-nitro-; .N-bromoacetyl-N-methyl-4-nitro-aniline; .N-(2-bromomethylcarbonyl)-N-methyl-4-nitroaniline; .2-Brom-4''-nitro-N-methylacetanilid
23543-31-9
98% min.
scale-up (10-1,000 kg)
C9H9BrN2O3
98% min.
scale-up (10-1,000 kg)
C9H9BrN2O3
KRO-37574
QC-211; N-methyl-4-nitrochloroacetanilide
2653-16-9
98% min.
scale-up (10-1,000 kg)
C9H9ClN2O3
98% min.
scale-up (10-1,000 kg)
C9H9ClN2O3
KRO-42914
1,3-dimethyl 2-[4-(methoxycarbonyl)-2-nitrophenyl]propanedioate
1160293-27-5
98% min.
scale-up (10-1,000 kg)
C13H13NO8
98% min.
scale-up (10-1,000 kg)
C13H13NO8
KRO-34912
[1,1''-Biphenyl]-3-carboxylic acid,2''-hydroxy-3''-nitro; 2-HYDROXY-3''''-NITRO-BIPHENYL-3-CARBOXYLIC ACID; BIP029; 2-HYDROXY-3A''A inverted exclamation markA''A A''A inverted exclamation markA''A-NITRO-BIPHENYL-3-CARBOXYLIC ACID
376591-95-6
98% min.
scale-up (10-1,000 kg)
C13H9NO5
98% min.
scale-up (10-1,000 kg)
C13H9NO5
KRO-29443
1-(3,4-dimethylphenyl)-3-methyl-3-pyrazolin-5-one
18048-64-1
98% min.
scale-up (10-1,000 kg)
C12H14N2O
98% min.
scale-up (10-1,000 kg)
C12H14N2O